Browsing Tag
HHS
3 posts
HIMS near 52-week low as FDA issues 30 GLP-1 warning letters
FDA sends 30 warning letters to GLP-1 compounders, targeting Hims & Hers Health (HIMS) as regulatory and legal pressure intensifies. Read what it means for investors and the sector.
HHS grants VSee Health FedRAMP High ATO, clearing path for U.S. government telehealth adoption
Find out how VSee Health’s FedRAMP High ATO from HHS positions it to expand secure telehealth across U.S. federal agencies.
HHS invests $590m in Moderna for mRNA-based pandemic influenza vaccines
The U.S. Department of Health and Human Services (HHS) has announced a monumental $590 million investment in Moderna,…